Showing results (131-140 of 239) with videos related to
Sort By:
Pageof 24
Cancer Research|December 6, 2015
Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung CancerKristin J Lastwika, Willie Wilson, Qing Kay Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2012
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibodyEvan J Lipson, William H Sharfman, Charles G Drake, et al.Cancer Immunology Research|November 6, 2014
PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutationNemanja Rodić, Robert A Anders, James R Eshleman, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of responseJ E Stein, A Soni, L Danilova, et al.Radiation Research|February 1, 1997
Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressureJ S Hahn, R D Braun, M W Dewhirst, et al.Science Immunology|October 13, 2019
Interleukin-36γ-producing macrophages drive IL-17-mediated fibrosisSven D Sommerfeld, Christopher Cherry, Remi M Schwab, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2017
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody ComparisonJoel C Sunshine, Peter L Nguyen, Genevieve J Kaunitz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2015
Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway BlockadeJanis M Taube, Geoffrey D Young, Tracee L McMiller, et al.Cancer Immunology Research|January 14, 2014
PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survivalEvan J Lipson, Jeremy G Vincent, Myriam Loyo, et al.Cell Reports. Medicine|February 22, 2023
Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinomaJulie Stein Deutsch, Evan J Lipson, Ludmila Danilova, et al.Pageof 24